Dolby Laboratories, INC Form 4 insider transactions

Dolby Laboratories CEO Kevin Yeaman exercised stock options, sold a portion of the acquired shares under a 10b5-1 plan, and gifted shares for charitable purposes.

Dolby Laboratories Director Tony Prophet sold 3,300 shares of Class A Common Stock for $67.85 per share under a pre-arranged trading plan.

Dolby Laboratories' SVP of Advanced Technology Group, Shriram Revankar, sold 3,000 shares of Class A Common Stock for $65.55 per share under a pre-arranged 10b5-1 trading plan.

John D. Couling, SVP of Entertainment at Dolby Laboratories, Inc., reported the sale of 6,164 shares of Class A Common Stock at $66.12 per share.

Dolby Laboratories' SVP & CFO, Robert J. Park, reported a disposition of 3,552 Class A common shares to cover tax withholding related to restricted stock unit vesting.

Dolby Laboratories President and CEO Kevin J. Yeaman exercised stock options and simultaneously sold an equivalent number of shares on October 14, 2025, as part of a Rule 10b5-1 plan.

Dolby Laboratories CEO Kevin Yeaman exercised stock options and subsequently sold an equal number of Class A Common Stock shares under a Rule 10b5-1 plan.

Dolby Laboratories' SVP of Advanced Technology Group, Shriram Revankar, reported the sale of 7,000 shares of Class A Common Stock for $74.92 per share, effective August 22, 2025.

Dolby Laboratories CEO Kevin Yeaman exercised stock options and subsequently sold 25,000 Class A Common Stock shares for approximately $72.31 per share under a pre-arranged 10b5-1 plan.

Dolby Laboratories President and CEO Kevin J. Yeaman reported the exercise of employee stock options and subsequent sale of Class A Common Stock shares on July 15 and 16, 2025, as part of a pre-arranged trading plan.

Dolby Laboratories President and CEO Kevin Yeaman executed a pre-planned transaction on June 24, 2025, exercising 25,000 employee stock options and simultaneously selling the same number of Class A Common Stock shares.

Dolby Laboratories President and CEO Kevin J. Yeaman engaged in a pre-scheduled transaction on June 10, 2025, exercising stock options and simultaneously selling an equivalent number of shares through a family trust.

Mark Andrew Sherman, EVP, General Counsel & Secretary of Dolby Laboratories, Inc., executed a pre-arranged transaction on June 4, 2025, exercising stock options and simultaneously selling an equivalent number of Class A Common Stock shares.

Mark Andrew Sherman, EVP, General Counsel & Secretary of Dolby Laboratories, Inc., sold 350 shares of Class A Common Stock for $74.97 per share, acquired through the company's Employee Stock Purchase Plan.

Shriram Revankar, SVP at Dolby Laboratories, reports a transaction involving Class A Common Stock related to tax withholding on vested restricted stock units.

John D. Couling, SVP, Entertainment at Dolby Laboratories, sold 675 shares of Class A Common Stock at $75.04 on May 5, 2025.

Dolby Laboratories CEO Kevin Yeaman transferred stock options to a revocable trust for estate planning purposes on February 27, 2025.

Todd Pendleton, SVP and Chief Marketing Officer at Dolby Laboratories, reports the exercise of stock options and sale of Class A Common Stock.

Dagmar Dolby, a director and significant shareholder of Dolby Laboratories, converted 510,000 shares of Class B Common Stock to Class A Common Stock and subsequently gifted them to unaffiliated charitable organizations on February 19, 2025.

Ryan Nicholson, VP, CAO and Corp. Controller of Dolby Laboratories, exercised stock options and sold shares of Class A Common Stock on February 5, 2025.

Director Simon Segars reports the acquisition of 3,140 restricted stock units in Dolby Laboratories, Inc.

Director Emily Rollins reports the acquisition of 3,140 restricted stock units in Dolby Laboratories, Inc.

Director Tony Prophet reported the acquisition of 3,140 restricted stock units of Dolby Laboratories Class A Common Stock on February 4, 2025.

Director Anjali Sud reports acquisition of 3,140 restricted stock units of Dolby Laboratories Class A Common Stock.

Director Peter Gotcher acquired 3,140 restricted stock units of Dolby Laboratories Class A Common Stock on February 4, 2025.

David Dolby, a director and 10% owner of Dolby Laboratories, Inc., was granted 3,140 restricted stock units on February 4, 2025, under the company's 2020 Stock Plan.

Director Avadis Tevanian reports acquisition of 3,140 restricted stock units of Dolby Laboratories Class A Common Stock.

Mark Andrew Sherman, EVP, General Counsel & Secretary at Dolby Laboratories, exercised stock options and sold shares on January 30, 2025.

Director Emily Rollins sold 1,000 shares of Dolby Laboratories Class A common stock on January 30, 2025, at a price of $84.9 per share.

Ryan Nicholson, VP, CAO and Corp. Controller at Dolby Laboratories, reported the acquisition of 7,328 restricted stock units and the disposal of 1,934 shares to cover tax obligations.